Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long Gao

Showing results (371-380 of 394) with videos related to

Pageof 40
Sort By:
World Journal of Gastroenterology|December 14, 2020
Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort studyChong-Fei Huang, Jun-Jun Huang, Ning-Ning Mi, et al.
The New England Journal of Medicine|October 19, 2012
Ustekinumab induction and maintenance therapy in refractory Crohn's diseaseWilliam J Sandborn, Christopher Gasink, Long-Long Gao, et al.
JAMA Dermatology|December 11, 2024
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality ImprovementAndrew Alexis, Amy McMichael, Neelam Vashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2024
Genome-wide single-cell and single-molecule footprinting of transcription factors with deaminaseRunsheng He, Wenyang Dong, Zhi Wang, et al.
Acta Pharmaceutica Sinica. B|May 25, 2026
Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivityMingzhen Bai, Ping Yue, Wenkang Fu, et al.
The British Journal of Dermatology|August 28, 2025
SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site InvolvementLinda Stein Gold, Alice B Gottlieb, April W Armstrong, et al.
National Science Review|March 11, 2025
A smart millimeter-wave base station for 6G application based on programmable metasurfaceJun Wei Zhang, Zhen Jie Qi, Li Jie Wu, et al.
The Journal of Clinical Investigation|June 1, 2022
α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody-positive individualsNicolai M Doliba, Andrea V Rozo, Jeffrey Roman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2021
Structure and activity of SLAC1 channels for stomatal signaling in leavesYa-Nan Deng, Hamdy Kashtoh, Quan Wang, et al.
Frontiers in Pharmacology|July 3, 2023
Lanatoside C decelerates proliferation and induces apoptosis through inhibition of STAT3 and ROS-mediated mitochondrial membrane potential transformation in cholangiocarcinomaChao Zhang, Hong-Ying Yang, Long Gao, et al.
Pageof 40

Showing results (371-380 of 394) with videos related to

Sort By:
Pageof 40
World Journal of Gastroenterology|December 14, 2020
Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort studyChong-Fei Huang, Jun-Jun Huang, Ning-Ning Mi, et al.
The New England Journal of Medicine|October 19, 2012
Ustekinumab induction and maintenance therapy in refractory Crohn's diseaseWilliam J Sandborn, Christopher Gasink, Long-Long Gao, et al.
JAMA Dermatology|December 11, 2024
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality ImprovementAndrew Alexis, Amy McMichael, Neelam Vashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2024
Genome-wide single-cell and single-molecule footprinting of transcription factors with deaminaseRunsheng He, Wenyang Dong, Zhi Wang, et al.
Acta Pharmaceutica Sinica. B|May 25, 2026
Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivityMingzhen Bai, Ping Yue, Wenkang Fu, et al.
The British Journal of Dermatology|August 28, 2025
SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site InvolvementLinda Stein Gold, Alice B Gottlieb, April W Armstrong, et al.
National Science Review|March 11, 2025
A smart millimeter-wave base station for 6G application based on programmable metasurfaceJun Wei Zhang, Zhen Jie Qi, Li Jie Wu, et al.
The Journal of Clinical Investigation|June 1, 2022
α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody-positive individualsNicolai M Doliba, Andrea V Rozo, Jeffrey Roman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2021
Structure and activity of SLAC1 channels for stomatal signaling in leavesYa-Nan Deng, Hamdy Kashtoh, Quan Wang, et al.
Frontiers in Pharmacology|July 3, 2023
Lanatoside C decelerates proliferation and induces apoptosis through inhibition of STAT3 and ROS-mediated mitochondrial membrane potential transformation in cholangiocarcinomaChao Zhang, Hong-Ying Yang, Long Gao, et al.
Pageof 40